Answers are grounded in this paper and cite their sources.
Genetic manipulation of HDAC4 reveals its potential role in metabolic alterations in mice, suggesting further investigation is needed.
Despite a remarkable knowledge about the specific roles of different histone deacetylases (HDACs) in different physiological and pathological processes, it is an unresolved question to what extent the “hidden” enzymatic activity of class IIa HDACs contributes to physiological remodeling or disease phenotypes. Compared to class I and class IIb HDACs, class IIa HDACs seem to possess a relatively low deacetylase activity towards acetylated lysines. However, they possess a very specific class IIa HDAC activity towards a trifluoroacetylated substrate in vitro. This activity is unique to the class IIa HDACs. An according substrate in vivo has yet to be discovered. This work was supposed to give insights into the functional role of the catalytic activity of Histone Deacetylase 4 (HDAC4). It addresses the question whether HDAC4 indeed is an enzyme in an in vivo context or whether it only serves as a scaffold or reader protein. Therefore, I generated an HDAC4H968Y mouse line with a single histidine to tyrosine substitution in the catalytic domain of HDAC4. In in vitro experiments with recombinant human HDAC4, this substitution led to a gain of class I and class IIb HDAC activity but at the same time to a clear loss of the specific class IIa HDAC activity. In cell-based assays this substitution did not affect global histone acetylation, class I HDAC binding, or cellular localization of HDAC4. In the mouse model this substitution led to an overall loss of specific class IIa HDAC activity while changes in global class I and class IIb HDAC activity were not recorded. I did not observe major transcriptional changes, no changes in global histone acetylation, or an altered susceptibility to β-adrenergic stress in the heart. However, I identified not yet described potential direct HDAC4 deacetylation targets by an acetyl proteomics approach and found metabolic alterations in terms of insulin and glucose tolerance in the HDAC4H968Y mice. Based on my findings I assume a critical role of HDAC4’s catalytic activity for maintenance of insulin secretion in pancreatic β-cells. However, further studies will be necessary to understand the mechanistic basis of my observations.
No takes yet. Share an insight, caveat, or question.
Friederike Charlotte Schreiter (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: